by Richard Daverman, PhD
November 27, 2013 -- BioPacific Investors, an angel group comprised of experienced US investors and life science executives, has been formed to invest in US and European life science companies that plan to establish or expand their operations in China or other emerging markets in Asia. The group expects that its investments, which will range from $250,000 to $1 million, will usually be the first outside funding for a company. More details....
Help employers find you! Check out all the jobs and post your resume.
